Top compounds associated with response to BTG4


Feature Type Standardized
Nominal ANOVA
mRNA Vinorelbine GDSC1000 pan-cancer AAC -0.081 0.02
mRNA BX-912 GDSC1000 pan-cancer AAC -0.068 0.02
mRNA XL765 CTRPv2 pan-cancer AAC 0.086 0.02
mRNA NSC95397 CTRPv2 pan-cancer AAC 0.075 0.02
mRNA Talazoparib GDSC1000 pan-cancer AAC -0.075 0.02
mRNA etoposide GDSC1000 pan-cancer AAC -0.077 0.02
mRNA Camptothecin GDSC1000 pan-cancer AAC -0.074 0.03
mRNA RAF265 CCLE pan-cancer AAC -0.11 0.03
mRNA Bortezomib FIMM pan-cancer AAC -0.31 0.03
mRNA NG-25 GDSC1000 pan-cancer AAC -0.062 0.03
Download CSV